Study showed 93% of patients responded with 67% achieving complete response HOUSTON ― A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment […]




